PL170935B1 - Sposób wytwarzania zawierajacej nifedypine kompozycji farmaceutycznej o powolnymuwalnianiu nifedypiny PL PL - Google Patents

Sposób wytwarzania zawierajacej nifedypine kompozycji farmaceutycznej o powolnymuwalnianiu nifedypiny PL PL

Info

Publication number
PL170935B1
PL170935B1 PL93300638A PL30063893A PL170935B1 PL 170935 B1 PL170935 B1 PL 170935B1 PL 93300638 A PL93300638 A PL 93300638A PL 30063893 A PL30063893 A PL 30063893A PL 170935 B1 PL170935 B1 PL 170935B1
Authority
PL
Poland
Prior art keywords
nifedipine
solvent
pharmaceutically acceptable
polyvinylpyrrolidone
acrylic polymer
Prior art date
Application number
PL93300638A
Other languages
English (en)
Polish (pl)
Other versions
PL300638A1 (en
Inventor
David Trigger
Original Assignee
Ethical Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethical Pharma Ltd filed Critical Ethical Pharma Ltd
Publication of PL300638A1 publication Critical patent/PL300638A1/xx
Publication of PL170935B1 publication Critical patent/PL170935B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
PL93300638A 1992-01-13 1993-01-12 Sposób wytwarzania zawierajacej nifedypine kompozycji farmaceutycznej o powolnymuwalnianiu nifedypiny PL PL PL170935B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929200607A GB9200607D0 (en) 1992-01-13 1992-01-13 Pharmaceutical compositions containing nifedipine and process for the preparation thereof
PCT/GB1993/000055 WO1993013773A1 (en) 1992-01-13 1993-01-12 Pharmaceutical compositions containing nifedipine and process for the preparation thereof

Publications (2)

Publication Number Publication Date
PL300638A1 PL300638A1 (en) 1994-03-21
PL170935B1 true PL170935B1 (pl) 1997-02-28

Family

ID=10708487

Family Applications (1)

Application Number Title Priority Date Filing Date
PL93300638A PL170935B1 (pl) 1992-01-13 1993-01-12 Sposób wytwarzania zawierajacej nifedypine kompozycji farmaceutycznej o powolnymuwalnianiu nifedypiny PL PL

Country Status (24)

Country Link
US (1) US5594013A (da)
EP (1) EP0620733B1 (da)
JP (1) JPH07503003A (da)
AT (1) ATE191144T1 (da)
AU (1) AU659529B2 (da)
CA (1) CA2126864A1 (da)
DE (2) DE4390075T1 (da)
DK (2) DK0620733T3 (da)
ES (1) ES2146227T3 (da)
FI (1) FI943316L (da)
GB (2) GB9200607D0 (da)
HU (2) HU219338B (da)
IS (1) IS1620B (da)
MY (1) MY110660A (da)
NL (1) NL9320021A (da)
NO (1) NO305223B1 (da)
NZ (1) NZ246374A (da)
PH (1) PH30985A (da)
PL (1) PL170935B1 (da)
PT (1) PT620733E (da)
RU (1) RU2106139C1 (da)
SE (1) SE9402457L (da)
WO (1) WO1993013773A1 (da)
ZA (1) ZA93195B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005262A1 (en) * 1992-09-10 1994-03-17 F.H. Faulding & Co. Limited Sustained release matrix composition
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
WO1997008950A1 (en) * 1995-09-07 1997-03-13 Fuisz Technologies, Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
CO4771151A1 (es) * 1996-01-19 1999-04-30 Rachitzky Falicman Pablo Alberto Procedimiento para la elaboracion de una preparacion farmace utica que contiene nifedipina y la preparacion farmaceutica obtenida mediante el mismo
JP3148256B2 (ja) * 1996-07-08 2001-03-19 エドワード メンデル カンパニー．，インコーポレーテッド 高用量難溶性薬物用持続放出マトリックス
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6264872B1 (en) 1997-12-30 2001-07-24 Kimberly-Clark Worldwide, Inc. Method of forming thin, embossed, textured barrier films
US6969529B2 (en) 2000-09-21 2005-11-29 Elan Pharma International Ltd. Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
US6706283B1 (en) 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
US6168806B1 (en) 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
EP1341521B1 (en) * 2000-11-20 2009-01-07 Elan Pharma International Limited Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
ES2233876T3 (es) * 2001-12-19 2005-06-16 Astrazeneca Ab Nuevo recubrimiento de pelicula que contiene un copolimero acrilato de etilo/metacrilato de metilo y poli (acetato de vinilo).
US6620900B2 (en) * 2002-02-07 2003-09-16 Isp Investments Inc. Proliferous copolymer of vinyl pyrrolidone and vinyl acetate
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
RU2220725C1 (ru) * 2002-08-01 2004-01-10 Закрытое акционерное общество "Брынцалов-А" Антиангинальное, антигипертензивное средство
EP1539270A1 (en) * 2002-09-18 2005-06-15 Medtronic Vascular, Inc. Controllable drug releasing gradient coatings for medical devices
AU2006232896A1 (en) * 2005-04-06 2006-10-12 Mallinckrodt Inc. Matrix-based pulse release pharmaceutical formulation
WO2007106111A2 (en) * 2005-07-01 2007-09-20 Elan Pharma International Limited Nanoparticulate and controlled release compositions comprising nilvadipine
JP5351490B2 (ja) * 2007-10-25 2013-11-27 バイエル薬品株式会社 ニフェジピン含有有核錠剤およびその製法
RU2629843C1 (ru) * 2016-05-24 2017-09-04 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Способ получения мази нифедипина (варианты)
CN115844845B (zh) * 2022-08-29 2025-03-14 迪沙药业集团有限公司 一种硝苯地平缓释制剂及制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
DE3172915D1 (en) * 1980-09-05 1985-12-19 Argus Chem Homogeneous storage-stable liquid barium-cadmium-triphosphite stabilizer systems for polyvinyl chloride resins
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
EP0078430B2 (de) * 1981-10-29 1993-02-10 Bayer Ag Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
EP0159604B1 (en) * 1984-04-09 1990-11-07 Toyo Boseki Kabushiki Kaisha Sustained-release preparation applicable to mucous membrane in oral cavity
DE3424553A1 (de) * 1984-07-04 1986-01-09 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
FR2579510B1 (fr) * 1985-03-29 1989-12-15 Demler Sa Ets Table vibrante pour la fabrication de produits en beton
FR2585174B1 (fr) * 1985-07-16 1987-11-27 Eurofarad Procede de fabrication d'un composant capacitif multicouche a dielectrique ceramique du type cordierite, et composant ainsi obtenu
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US4970075A (en) * 1986-07-18 1990-11-13 Euroceltique, S.A. Controlled release bases for pharmaceuticals
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
ES2077023T3 (es) * 1989-03-10 1995-11-16 Yamanouchi Pharma Co Ltd Material de recubrimiento que controla la liberacion de un medicamento para formulaciones de actividad prolongada.
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
JPH0729926B2 (ja) * 1989-07-25 1995-04-05 大塚製薬株式会社 易吸収性製剤用組成物

Also Published As

Publication number Publication date
ES2146227T3 (es) 2000-08-01
GB9413101D0 (en) 1994-08-31
GB9200607D0 (en) 1992-03-11
DE69328245D1 (de) 2000-05-04
GB2277872B (en) 1995-10-04
MY110660A (en) 1999-01-30
NO942622D0 (no) 1994-07-12
PH30985A (en) 1997-12-23
HU219338B (en) 2001-03-28
HUT67426A (en) 1995-04-28
JPH07503003A (ja) 1995-03-30
EP0620733A1 (en) 1994-10-26
DE69328245T2 (de) 2000-10-12
PL300638A1 (en) 1994-03-21
NL9320021A (nl) 1995-06-01
SE9402457D0 (sv) 1994-07-12
NO305223B1 (no) 1999-04-26
DK83794A (da) 1994-07-11
RU94035739A (ru) 1996-09-20
WO1993013773A1 (en) 1993-07-22
ZA93195B (en) 1993-08-16
CA2126864A1 (en) 1993-07-22
PT620733E (pt) 2000-08-31
NO942622L (no) 1994-07-12
EP0620733B1 (en) 2000-03-29
IS3966A (is) 1993-07-14
IS1620B (is) 1996-10-18
US5594013A (en) 1997-01-14
AU659529B2 (en) 1995-05-18
NZ246374A (en) 1995-07-26
DE4390075T1 (de) 1994-12-01
HU210539A9 (en) 1995-05-29
ATE191144T1 (de) 2000-04-15
HU9401850D0 (en) 1994-09-28
FI943316A0 (fi) 1994-07-12
GB2277872A (en) 1994-11-16
FI943316A7 (fi) 1994-07-12
DK0620733T3 (da) 2000-07-24
AU3263693A (en) 1993-08-03
FI943316L (fi) 1994-07-12
SE9402457L (sv) 1994-09-12
RU2106139C1 (ru) 1998-03-10

Similar Documents

Publication Publication Date Title
PL170935B1 (pl) Sposób wytwarzania zawierajacej nifedypine kompozycji farmaceutycznej o powolnymuwalnianiu nifedypiny PL PL
US5051263A (en) Controlled-release formulations
TW499312B (en) Immediate release tablet cores of insoluble drugs having sustained-release coating
DE69105222T2 (de) Auf quervernetzte Polymere aufgebrachte und mit Polymerfilmen beschichtete therapeutische Zusammensetzungen mit kontrollierter Freisetzung von Medikamenten und deren Herstellungsverfahren.
US5543099A (en) Process to manufacture micronized nifedipine granules for sustained release medicaments
RS50055B (sr) Kompozicije oksikodona sa kontrolisanim oslobađanjem
RU2235540C2 (ru) Способ получения пероральной препаративной формы пролонгированного действия с регулируемым высвобождением активного вещества в зависимости от вида и количества наполнения желудка и пищеварительного тракта
JPH0122245B2 (da)
US4911921A (en) High ibuprofen content granulations
DE20219293U1 (de) Pharmazeutische Pellets enthaltend Tamsulosin
WO2017032908A1 (en) Pharmaceutical composition comprising amorphous posaconazole
WO1997033574A1 (fr) Comprimes a liberation prolongee a base de valproate metallique
PT98758B (pt) Processo para a preparacao de uma composicao sob a forma de comprimido ou drageia contendo um ingrediente activo de preferencia um derivado de aminoguanidina sensivel ao calor luz e humidade tendo estretura cristalina monoclinica
IL177402A (en) Composition for oral administration of tamsulosin hydrochloride
CA2757752A1 (en) Process for producing rapidly disintegrating spheroids (pellets), granules and/or mixtures thereof
US5492700A (en) Process and composition for the development of controlled release gemfibrozil dosage form
NZ231954A (en) Aqueous coating formulations for coating aspirin granules; aspirin tablets having zero order release kinetics
US5358723A (en) Process and composition for the development of controlled release gemfibrozil dosage form
JP2678556B2 (ja) 抗不整脈薬剤及びその製造方法
JP2008184393A (ja) アクリルコポリマーとの混合粉砕による難水溶性薬物の溶解性改善及び放出制御型粒子の調製
WO1993010775A1 (en) Process and composition for the development of controlled release gemfibrozil dosage form
JPWO2003032998A1 (ja) 徐放性微粒子及びその製造方法
RS50058B (sr) Kompozicije oksikodona sa kontrolisanim oslobađanjem
MXPA06007316A (en) Controlled-release pharmaceutical formulation
PL176474B1 (pl) Preparat farmaceutyczny o kontrolowanym uwalnianiu i sposoby wytwarzania preparatu farmaceutycznego o kontrolowanym uwalnianiu